Back to results
US 2022/0184034 A1Published application
Methods for treating cutaneous metastatic cancers
AssigneeAdgero Biopharmaceuticals Holdings, Inc.
InventorSteve Rychnovsky
Life of this patent
Estimating the term…
Abstract
A method for treating a cutaneous metastatic cancer comprising administering tin ethyl etiopurprin (SnET2) to a subject suffering from a cutaneous metastatic cancer and exposing the subject at a pre-selected site with light at a wavelength and at a light dose sufficient to effect treatment to effect treatment.
Claims29
A method for treating a cutaneous metastatic cancer, comprising:
- (a) administering tin ethyl etiopurpurin (SnET2) at a dose from about 0.5 to about 1.0 mg/kg to a subject suffering from a cutaneous metastatic cancer, and
- (b) exposing the subject at a pre-selected site with light at a wavelength and at a light dose sufficient to effect treatment.
Dependencies are inferred from the claim text.